Physician profile
Christopher Lang
NPI 1063462067
$858.30
in general payments reported to CMS, 2019-2025
15 companies · $57.38 in 2025
The $57.38 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $438 · 2022: $66.34 · 2023: $154 · 2024: $143 · 2025: $57.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $184.76 | 2021 | |
| Depuy Synthes Sales INC. | $115.38 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $103.89 | 2021 | |
| Stryker Corporation | $100.40 | 2022-2023 | T2 Alpha, Osteoset |
| Onkos Surgical, INC. | $79.85 | 2023-2025 | Eleos Limb Salvage System |
| Protega Pharmaceutials INC | $57.78 | 2024 | Roxybond |
| Ferring Pharmaceuticals INC. | $34.32 | 2021-2024 | Euflexxa |
| Vericel Corporation | $33.83 | 2024 | Maci |
| Sanara Medtech INC. | $30.73 | 2024 | Celleraterx |
| Theragen, INC. | $29.55 | 2023 | Kneehab Xp |
| Baxter Healthcare | $27.54 | 2022 | |
| Ethicon US, LLC | $20.35 | 2021 | |
| Innovation Technologies INC | $16.19 | 2022 | |
| Orthofix Medical, INC. | $15.03 | 2025 | Physio-Stim |
| Heron Therapeutics, INC. | $8.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.